glp 1 gestational diabetes Preconception GLP-1 receptor agonist use may reduce pregnancy risks Targeting GLP-1, GIP & GCG

Furthermore, the rising prevalence of obesity has significantly contributed to the growing utilization of GLP-1 analogs in the treatment of obesity, which is significantly driving the GLP-1 analogues market

Barrera JG, Sandoval DA, DAlessio DA, et al

-C) 18 would give a similar projection

While the long-term safety and effectiveness of GLP-1RA for other indications like kidney disease and fatty liver still need verification, attention and research investment in GLP-1RAs for obesity and related conditions are keeping increasing, driving further scientific and medical advancements in metabolic diseases

Until recently, therapeutic strategies remained limited to lifestyle interventions, with few pharmacological options demonstrating meaningful clinical benefit